Christopher P. Lowe - Oct 5, 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
COO & Chief Financial Officer
Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Stock symbol
QNCX
Transactions as of
Oct 5, 2021
Transactions value $
-$216,635
Form type
4
Date filed
10/7/2021, 06:24 PM
Previous filing
Aug 18, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $272K +4.96K +8.27% $54.85 65K Oct 5, 2021 Direct
transaction QNCX Common Stock Sale -$489K -4.96K -7.64% $98.50* 60K Oct 5, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (Right to Buy) Options Exercise $0 -4.96K -4.96% $0.00 95K Oct 5, 2021 Common Stock 4.96K $54.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 1/48th of the shares subject to the option shall vest and become exercisable monthly over four years.